Surveillance of drug-resistant Mycobacterium tuberculosis in The Gambia

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 4, 2003, Pages 390-393

  Adegbola, Richard A ^a   Hill, P ^a   Baldeh, I ^a   Otu, J ^a   Sarr, R ^a   Sillah, J ^a   Lienhardt, C ^a   Corrah, T ^a   Manneh, K ^b   Drobniewski, F ^c   McAdam, K P W J ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b Natl TB/Leprosy Control Programme   (Gambia)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Drug resistance; Mycobacterium tuberculosis; The Gambia

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOLOGICAL MONITORING; CONTROLLED STUDY; FEMALE; GAMBIA; HUMAN; INFECTION RATE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; FEMALE; GAMBIA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; PREVALENCE; SEX DISTRIBUTION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 12444317529     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Iseman M D. Treatment of multi-drug resistant tuberculosis. N Engl J Med 1993; 329: 784-791.
2. Pablos-Mendez A, Raviglione M C, Laszlo A, et al. Global surveillance for antituberculosis drug resistance, 1994-1997. N Engl J Med 1998; 338: 1641-1649.
3. Mitchison D A, Nunn A J. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133: 423-430.
4. Chaulet P, Boulahbal F, Grosset J. Surveillance of drug resistance for tuberculosis control: why and how? Tubercle Lung Dis 1995; 76: 487-492.
5. National Leprosy and Tuberculosis Programme. Annual Report. The Gambia: KNCV, 2001.
6. WHO/IUATLD Global Project on Anti-Tuberculous Drug Resistance Surveillance. Anti-tuberculous drug-resistance in the world. WHO/TB/97.229. Geneva: WHO, 1997.
7. Heifets L B, Good R B. Current laboratory methods for the diagnosis of tuberculosis. In: Bloom B R, ed. Tuberculosis: protection, pathogenesis, and control. American Society for Microbiology, Washington, DC, 1994: pp 85-110.
8. Collins C H, Grange J M, Yates M D. Tuberculosis: bacteriology, organization and practice. 2nd ed. Oxford, UK: Butterworth-Heinmann, 1997.
9. WHO/IUATLD guidelines for surveillance of drug resistance in tuberculosis. WHO/TB/96.216. Geneva: WHO, 1996.
10. Githui W A, Juma E S, van Gorkom J, Kibuga D, Odhiambo J, Drobniewski F. Antituberculosis drug resistance surveillance in Kenya, 1995. Int J Tuberc Lung Dis 1998; 2: 499-505.